Format
Sort by
Items per page

Send to

Choose Destination

Best matches for olmesartan:

Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential Hypertension. Shiga Y et al. Int Heart J. (2017)

Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study. Williams B et al. Hypertension. (2017)

Olmesartan. Al-Majed AA et al. Profiles Drug Subst Excip Relat Methodol. (2017)

Search results

Items: 1 to 20 of 1513

1.

Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.

Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Turski WA.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Oct 29. doi: 10.1007/s00210-018-1572-7. [Epub ahead of print]

PMID:
30370429
2.

Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin.

Ichikawa H, Narita I, Narita M, Tanno T, Yokono Y, Kimura Y, Tanaka M, Osanai T, Okumura K, Tomita H.

Int Heart J. 2018 Oct 25. doi: 10.1536/ihj.17-582. [Epub ahead of print]

3.

Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan.

Omboni S, Volpe M.

Cardiovasc Ther. 2018 Oct 25:e12471. doi: 10.1111/1755-5922.12471. [Epub ahead of print] Review.

PMID:
30358114
4.

Morning Home Blood Pressure and Cardiovascular Events in Japanese Hypertensive Patients.

Kario K, Iwashita M, Okuda Y, Sugiyama M, Saito I, Kushiro T, Teramukai S, Shimada K.

Hypertension. 2018 Oct;72(4):854-861. doi: 10.1161/HYPERTENSIONAHA.118.11388.

PMID:
30354719
5.

Plantar psoriasis associated with olmesartan.

Charfi O, Badri T, Aouinti I, Lakhoua G, Kastalli S, El Aidli S, Zaïem A.

Curr Drug Saf. 2018 Oct 17. doi: 10.2174/1574886313666181017120629. [Epub ahead of print]

PMID:
30332975
6.

Cardiac Glutathione Levels Increase in Response to Glucose in Diabetic Rats.

Thorwald MA, Godoy-Lugo JA, Rodriguez GJ, Rodriguez MA, Jamal M, Kinoshita H, Nakano D, Nishiyama A, Forman HJ, Ortiz RM.

Free Radic Biol Med. 2018 Oct 11. pii: S0891-5849(18)31281-4. doi: 10.1016/j.freeradbiomed.2018.10.405. [Epub ahead of print]

PMID:
30316779
7.

Hyporheic Exchange Controls Fate of Trace Organic Compounds in an Urban Stream.

Schaper JL, Posselt M, McCallum JL, Banks EW, Hoehne A, Meinikmann K, Shanafield MA, Batelaan O, Lewandowski J.

Environ Sci Technol. 2018 Oct 22. doi: 10.1021/acs.est.8b03117. [Epub ahead of print]

PMID:
30293423
8.

Olmesartan-induced enteropathy.

Onteddu NK, Pulivarthi VSKK, Ginnavaram M, Kedika R.

BMJ Case Rep. 2018 Oct 2;2018. pii: bcr-2018-224411. doi: 10.1136/bcr-2018-224411.

PMID:
30279248
9.

Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension.

Ferdinand KC, Bakris GL, Cushman WC, Weber MA, Lloyd E, Wu J, White WB.

Am J Cardiol. 2018 Nov 1;122(9):1496-1505. doi: 10.1016/j.amjcard.2018.07.022. Epub 2018 Aug 4.

10.
11.

[Olmesartan therapy and enteropathy: About two cases and review of the literature].

Sadki A, Le Besnerais M, Héron F, Marie I.

Rev Med Interne. 2018 Aug 30. pii: S0248-8663(18)30674-X. doi: 10.1016/j.revmed.2018.08.006. [Epub ahead of print] French.

PMID:
30174111
12.

Albuminuria during treatment with angiotensin type II receptor blocker is a predictor for GFR decline among non-diabetic hypertensive CKD patients.

Yu MY, Kim DK, Park JH, Shin SJ, Lee SH, Choi BS, Lim CS, Chin HJ.

PLoS One. 2018 Aug 27;13(8):e0202676. doi: 10.1371/journal.pone.0202676. eCollection 2018.

13.

Protective effect of angiotensin II receptor blocker against oxidative stress and inflammation in an oral mucositis experimental model.

Araújo AA, Araújo LS, Medeiros CACX, Leitão RFC, Brito GAC, Costa DVDS, Guerra GCB, Garcia VB, Lima MLS, Araújo Junior RF.

J Oral Pathol Med. 2018 Nov;47(10):972-984. doi: 10.1111/jop.12775. Epub 2018 Sep 19.

PMID:
30125396
14.

Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA) : A cluster-randomized trial.

Rohla M, Tscharre M, Huber K, Weiss TW.

Wien Klin Wochenschr. 2018 Aug 15. doi: 10.1007/s00508-018-1374-4. [Epub ahead of print]

PMID:
30112584
15.

Angiotensin II Type 1 Receptor Homology Models: A Comparison Between In Silico and the Crystal Structures.

Kellici TF.

Methods Mol Biol. 2018;1824:449-460. doi: 10.1007/978-1-4939-8630-9_27.

PMID:
30039424
16.

New Onset Villous Atrophy in a Patient With Celiac Disease.

Cartee AK, Reyes Genere JP, Oxentenko AS.

Gastroenterology. 2018 Oct;155(4):988-989. doi: 10.1053/j.gastro.2018.03.070. Epub 2018 Jul 17. No abstract available.

PMID:
30025705
17.

Development of efficient one-pot three-component assembly of trityl olmesartan medoxomil.

Toplak Časar R, Časar Z.

Bioorg Med Chem. 2018 Aug 7;26(14):4348-4359. doi: 10.1016/j.bmc.2018.06.036. Epub 2018 Jun 28.

PMID:
30006144
18.

Olmesartan.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

19.

Angiotensin receptor and tumor necrosis factor-α activation contributes to glucose intolerance independent of systolic blood pressure in obese rats.

Rodriguez R, Lee A, Mathis KW, Broome HJ, Thorwald M, Martinez B, Nakano D, Nishiyama A, Ryan MJ, Ortiz RM.

Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F1081-F1090. doi: 10.1152/ajprenal.00156.2018. Epub 2018 Jul 11.

PMID:
29993275
20.

Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats.

Rodriguez R, Moreno M, Lee AY, Godoy-Lugo JA, Nakano D, Nishiyama A, Parkes D, Awayda MS, Ortiz RM.

Hypertens Res. 2018 Oct;41(10):798-808. doi: 10.1038/s41440-018-0070-0. Epub 2018 Jul 9.

Supplemental Content

Loading ...
Support Center